BCAB
Bioatla Inc
NASDAQ: BCAB · HEALTHCARE · BIOTECHNOLOGY
$4.21
+4.21% today
Updated 2026-04-30
Market cap
$8.07M
P/E ratio
—
P/S ratio
4.04x
EPS (TTM)
$-50.50
Dividend yield
—
52W range
$4 – $72
Volume
1.0M
Bioatla Inc (BCAB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-35.32M | $-9.64M | $-36.33M | $-62.21M | $-90.42M | $-104.02M | $-71.94M | $-48.20M |
| Capital expenditures | $988000.00 | $1.51M | $590000.00 | $924000.00 | $268000.00 | $98000.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $2637.00 | $-6403.00 | $3.02M | $25.12M | $14.56M | $13.54M | $8.92M | $5.43M |
| Free cash flow | $-36.30M | $-11.15M | $-36.92M | $-63.14M | $-90.69M | $-104.11M | $-71.94M | $-48.20M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $6.37M | $-29.47M | — | — | — |